Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2025-12-25 @ 1:06 AM
NCT ID:
NCT00376493
Eligibility Criteria:
Inclusion Criteria:
* History of intrauterine manipulation with contaminated objects.
* Vaginal secretion with fetid odor
* Presence of pus flowing through the cervical uterine
* Presence of peritonitis
* Leucocytosis (\> 14,000 leucocytes/mL)
* Vasodilatation, bounding pulse and paradoxically warm periphery with tachycardia (Heart rate\> 110 bpm)
* Cyanosis and/or paleness
* tachypnea(\> 30mpm)
* Arterial hypotension (SAP\< 90mmHg)
* Oliguria
* Fever (\> or = than 37,8°C)
Exclusion Criteria:
* Refusal to participate in the project
* Prior use of antibiotics within one week
* Known allergy to Doxycycline or Metronidazole
* Presence of tubo-ovarian abscess
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
14 Years
Maximum Age:
50 Years
Study:
NCT00376493
Study Brief:
Protocol Section:
NCT00376493